Alliance Pharma plc (LON:APH – Get Free Report) shares reached a new 52-week high on Tuesday . The company traded as high as GBX 61.60 ($0.77) and last traded at GBX 61.20 ($0.76), with a volume of 5385101 shares trading hands. The stock had previously closed at GBX 61.20 ($0.76).
Alliance Pharma Stock Performance
The firm has a market capitalization of £330.83 million, a price-to-earnings ratio of -1,020.00, a P/E/G ratio of 1.04 and a beta of 0.67. The company has a 50-day moving average price of GBX 49.65 and a 200-day moving average price of GBX 43.91. The company has a quick ratio of 1.42, a current ratio of 2.93 and a debt-to-equity ratio of 47.46.
About Alliance Pharma
Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. The company also offers medicines, medical devices, food supplements, and cosmetics.
Read More
- Five stocks we like better than Alliance Pharma
- 5 discounted opportunities for dividend growth investors
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- How to Find Undervalued Stocks
- What Does the Future Hold for Eli Lilly?
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for Alliance Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alliance Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
